174 related articles for article (PubMed ID: 8859004)
1. Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.
Gartside SE; McQuade R; Sharp T
J Pharmacol Exp Ther; 1996 Oct; 279(1):277-83. PubMed ID: 8859004
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems.
Gartside SE; McQuade R; Sharp T
Neuropharmacology; 1997; 36(11-12):1697-703. PubMed ID: 9517441
[TBL] [Abstract][Full Text] [Related]
3. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis.
McQuade R; Sharp T
J Neurochem; 1997 Aug; 69(2):791-6. PubMed ID: 9231740
[TBL] [Abstract][Full Text] [Related]
4. Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats.
Aguirre N; Galbete JL; Lasheras B; Del Río J
Eur J Pharmacol; 1995 Jul; 281(1):101-5. PubMed ID: 8566108
[TBL] [Abstract][Full Text] [Related]
5. Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nuclei: effect of a neurotoxic amphetamine.
McQuade R; Sharp T
Neuroscience; 1995 Oct; 68(4):1079-88. PubMed ID: 8544983
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.
Adell A; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):237-44. PubMed ID: 1714040
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
[TBL] [Abstract][Full Text] [Related]
8. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways.
Casanovas JM; Artigas F
J Neurochem; 1996 Nov; 67(5):1945-52. PubMed ID: 8863499
[TBL] [Abstract][Full Text] [Related]
11. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
12. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study.
Malagié I; Trillat AC; Jacquot C; Gardier AM
Eur J Pharmacol; 1995 Nov; 286(2):213-7. PubMed ID: 8605960
[TBL] [Abstract][Full Text] [Related]
14. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
15. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: the role of corticosteroids.
Aguirre N; Frechilla D; García-Osta A; Lasheras B; Del Río J
J Neurochem; 1997 Mar; 68(3):1099-105. PubMed ID: 9048755
[TBL] [Abstract][Full Text] [Related]
17. 3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus.
Bonkale WL; Austin MC
Neuroscience; 2008 Jul; 155(1):270-6. PubMed ID: 18515011
[TBL] [Abstract][Full Text] [Related]
18. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
[TBL] [Abstract][Full Text] [Related]
20. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
